Related Experiment Video

Updated: Jul 22, 2026

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

Chlamydia pneumoniae and luminal narrowing after coronary angioplasty

K J Mattila1, J T Juvonen, M K Kotamäki

  • 1Helsinki University Hospital, Helsinki, Finland. kimmo.mattila@hus.fi

Journal of Internal Medicine
|July 17, 2001
PubMed

Insights

This study found no link between Chlamydia pneumoniae infection and arterial narrowing after percutaneous transluminal coronary angioplasty (PTCA). Other factors like smoking and diabetes were associated with restenosis in coronary heart disease patients.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Interventional Cardiology

Background:

  • Chlamydia pneumoniae has been implicated in atherosclerotic vascular disease.
  • A potential association between C. pneumoniae and restenosis post-percutaneous transluminal coronary angioplasty (PTCA) has been observed.

Purpose of the Study:

  • To investigate the role of Chlamydia pneumoniae in the luminal narrowing of coronary arteries following PTCA.

Main Methods:

  • A 6-month, non-interventional follow-up study.
  • 122 patients with coronary heart disease (CHD) undergoing PTCA were monitored.
  • Assessed C. pneumoniae antibody levels and immune complexes, correlating with luminal narrowing.

Main Results:

  • No significant association was found between C. pneumoniae antibody levels or immune complexes and luminal narrowing post-PTCA.
  • Multivariate analysis identified smoking, plasma endothelin, and diabetes as significant factors in luminal narrowing.
  • Serologic parameters for C. pneumoniae remained stable throughout the follow-up period.

Conclusions:

  • The study findings do not support a role for Chlamydia pneumoniae in the development of luminal narrowing after PTCA.
  • Risk factors such as smoking, elevated endothelin, and diabetes are more strongly associated with post-PTCA restenosis.
Abstract

More Related Videos

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...